Compound Edaravone Injection for Acute Ischemic Stroke, a Multi-center, Randomized, Double-blind, Multi-dose, Parallel, and Controlled Phase II Trial

Next Previous
Trial Profile

Compound Edaravone Injection for Acute Ischemic Stroke, a Multi-center, Randomized, Double-blind, Multi-dose, Parallel, and Controlled Phase II Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jul 2015

At a glance

  • Drugs Borneol/edaravone (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Sponsors Jiangsu Simcere Pharmaceutical

    • Most Recent Events

    • 23 Mar 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 22 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top